Quarterly report pursuant to Section 13 or 15(d)

Revenues from Contracts and Significant Customers (Company's product revenue) (Details)

v3.24.1.1.u2
Revenues from Contracts and Significant Customers (Company's product revenue) (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Product revenue, net $ 13,030 $ 12,165
Collaboration revenue   181
Other revenue   48
Net revenue 13,030 12,429
Related Party    
Revenue - related party   35
Qbrexza    
Product revenue, net 5,017 4,094
Accutane    
Product revenue, net 5,819 4,648
Amzeeq    
Product revenue, net 755 1,193
Zilxi    
Product revenue, net 273 314
Other Legacy Product Revenue    
Product revenue, net $ 1,166 $ 1,916